Supplementary Figures S1 and S2 from A Phase I Trial to Evaluate Antibody-Dependent Cellular Cytotoxicity of Cetuximab and Lenalidomide in Advanced Colorectal and Head and Neck Cancer
Year: 2023
Type: supplementary-materials
Abstract: Figure S1. Serum cytokine analysis; Figure S2. Flow cytometric analysis of immune cell types.
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362494550